• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Recent Advances in the Study of 2-Fluoro-5-(2-fluorophenyl)phenol (CAS: 1214341-66-8) in Chemical Biology and Pharmaceutical Research

2-Fluoro-5-(2-fluorophenyl)phenol (CAS: 1214341-66-8) is a fluorinated phenolic compound that has recently garnered significant attention in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This compound, characterized by the presence of two fluorine atoms on its aromatic rings, exhibits enhanced stability and bioavailability, making it a promising candidate for drug development. Recent studies have explored its role as an intermediate in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and other targeted therapies.

One of the key areas of interest is the compound's utility in the synthesis of small-molecule inhibitors targeting protein kinases, which are critical regulators of cellular signaling pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 2-fluoro-5-(2-fluorophenyl)phenol exhibit potent inhibitory activity against specific kinases involved in cancer progression. The study highlighted the compound's ability to modulate kinase activity through selective binding to the ATP-binding site, thereby offering a potential avenue for the development of novel anticancer agents.

In addition to its applications in oncology, 2-fluoro-5-(2-fluorophenyl)phenol has also been investigated for its potential in neurodegenerative disease research. A recent preprint on bioRxiv reported that fluorinated phenolic compounds, including 1214341-66-8, exhibit neuroprotective effects in in vitro models of Alzheimer's disease. The researchers attributed these effects to the compound's ability to scavenge reactive oxygen species (ROS) and reduce oxidative stress, which are key contributors to neuronal damage in neurodegenerative disorders.

The synthetic pathways for 2-fluoro-5-(2-fluorophenyl)phenol have also been optimized in recent years, with a focus on improving yield and scalability. A 2022 publication in Organic Process Research & Development detailed a novel catalytic method for the fluorination of phenolic compounds, which significantly reduced the use of hazardous reagents and improved the overall efficiency of the synthesis. This advancement is particularly relevant for industrial-scale production, where cost-effectiveness and environmental considerations are paramount.

Despite these promising developments, challenges remain in the clinical translation of 2-fluoro-5-(2-fluorophenyl)phenol-based therapeutics. Pharmacokinetic studies have revealed variability in the compound's metabolic stability across different biological systems, necessitating further optimization of its chemical structure. Ongoing research aims to address these limitations by exploring structural analogs and prodrug strategies to enhance bioavailability and reduce off-target effects.

In conclusion, 2-fluoro-5-(2-fluorophenyl)phenol (CAS: 1214341-66-8) represents a versatile and promising scaffold in chemical biology and drug discovery. Its applications span from oncology to neurodegenerative diseases, and recent advancements in synthetic chemistry have further bolstered its potential for therapeutic development. Future research should focus on overcoming pharmacokinetic challenges and expanding the compound's utility in targeted therapies, paving the way for its eventual clinical application.

• 1261979-12-7(2-fluoro-5-(4-fluoro-3-methylphenyl)phenol)
• 1261950-20-2(2-fluoro-5-(2-fluoro-5-methylphenyl)phenol)
• 1261965-33-6(2-fluoro-5-(2,4,6-trifluorophenyl)phenol)
• 612092-34-9(4-(2-Fluorophenyl)-2-fluorophenol)
• 1261657-02-6(5-(2,3-Difluorophenyl)-2-fluorophenol)
• 1261918-09-5(5-(2,5-Difluorophenyl)-2-fluorophenol)
• 1261952-34-4(5-(2,4-Difluorophenyl)-2-fluorophenol)
• 1261995-09-8(2-Fluoro-4-(2-fluoro-5-methylphenyl)phenol)
• 1261918-03-9(2-Fluoro-4-(2-fluoro-4-methylphenyl)phenol)
• 1261888-55-4(2-fluoro-5-(2-fluoro-4-methylphenyl)phenol)